Analysis of the cloned protease III gene (ptr) from Escherichia coli K-12 has demonstrated that in addition to the previously characterized 110,000-Mr protease III protein, a second 50,000-Mr polypeptide (p50) (30 ,uM) were then added to the medium, and at the time points of 0, 10, 20, 30, 45, 60, and 90 min after the addition of [35S]methionine, 0.5-ml samples were removed to 0.5 ml of spectinomycin (100 ,ug/ml) and processed to produce periplasmic extracts as well as shocked-cell extracts (membrane and cytoplasmic components). The extracts were concentrated and subjected to SDS-polyacrylamide electrophoresis as described above. The gels were then fixed, stained, dried, and autoradiographed.
endopeptidase which has been shown to have proteolytic activity on a limited number of small polypeptides of less than 6,000 Mr such as insulin, glucagon, and autoclaved ,-galactosidase fragments (2) . Swamy and Goldberg (14) have demonstrated that the majority of protease III activity (called protease Pi [for periplasmic insulin-degrading] in their nomenclature) is normally located in the periplasmic space. Since the reported protease III mutants have no detectable phenotypic alterations (3), the role of this enzyme in the metabolism of the cell has not yet been identified.
Recently, the structural gene for protease III was cloned as a part of a 19-kilobase BamHI fragment (5) . Initial characterization of the fragment showed that ptr was physically located between the recB and recC genes. Preliminary maxicell experiments suggested that the ptr structural gene encoded two polypeptides of 110,000 and 50,000 Mr. In this communication, it is shown that the smaller protein is derived from the 110,000-Mr species, but does not possess proteolytic activity on a normal protease III substrate, insulin. In addition, both polypeptides are found in the periplasmic space. Finally, it has been shown that deletion of the ptr gene does not cause any demonstrable phenotypic alterations to the bacteria. The amplification of protease III activity has permitted the development of an improved purification procedure.
MATERIALS AND METHODS
Strains and media. The Escherichia coli K-12 strains and plasmids used are listed in Table 1 . The media employed were Luria broth (10) , Luria broth supplemented with 2% agar, and K medium (15) . Plasmids and Tnl000 insertions in the plasmids have been described previously (5 (8) . Spectinomycin (100 ,ug/ml) and unlabeled methionine (30 ,uM) were then added to the medium, and at the time points of 0, 10, 20, 30, 45, 60, and 90 min after the addition of [35S]methionine, 0.5-ml samples were removed to 0.5 ml of spectinomycin (100 ,ug/ml) and processed to produce periplasmic extracts as well as shocked-cell extracts (membrane and cytoplasmic components). The extracts were concentrated and subjected to SDS-polyacrylamide electrophoresis as described above. The gels were then fixed, stained, dried, and autoradiographed.
Enzyme activity. Protease III activity on insulin was measured by the method of Goldberg et al. (6) . The reaction mixture (500 ,ul) contained 10 Fig. 1 ).
15,000 cpm. After 1 h at 37°C, the reaction was terminated by the addition of 40 ,ul of 30 mg of bovine serum albumin per ml and 120 ,ul of 50% trichloroacetic acid. After 30 min at 40C, the samples were centrifuged at 15,000 x g for 10 min, and the 125I remaining in the supernatant was quantitated by scintillation spectrometry. One unit of protease III activity is defined as that amount of protein degrading 1 ,ug of a-insulin in 1 h at 37°C. Periplasmic extracts from cultures grown in K medium were used to analyze protease activity in various genetic backgrounds. Protein deterniinations were by the method of Bradford (1).
RESULTS
Relationship of protease III and p50. The isolation of the Tnl000 insertions shown in Fig. 1 has been described previously (5) . In this study these insertions were used to analyze the relationship between protease III (p110) and the 50,000-Mr (p50) protein which appeared to map in the same place. Both proteins were originally identified in the analysis of the recB and recC genes which closely flank this region. In addition, Fig. 1 a,lso shows the extent of the deletion in this region of the E. coli chromosome in strain AC42 as determined by Southern analysis (data not shown). The viability of this strain indicates that ptr is not an essential gene. TnlOM Insertior ous Tn1000 insertions in the ptr locus of pCDK3 as well as a subclone (pCDK35) which carries only the ptr coding sequences. Osmotic shockates (12) , which represent periplasmically located proteins, and the shocked-cell lysates were analyzed by SDS-polyacrylamide gel electrophoresis. Since P-lactamase (bla) is transported to the periplasm (9) and chloramphenicol acetyl transferase (cat) and thymidylate synthetase (thyA) are located in the cytoplasm, these three plasmid-specified gene products served as internal controls for the two cell fractions. Protease III (p110), p50, and ,-lactamase were seen in the osmotic shockate fraction when pCDK3-or pCDK35-containing maxicells were labeled with [35S]methionine (Fig.  2, lanes 6 and 7) . The next three lanes show the osmotic shockate fractions pf pCDK3 that contain the three different TnJOOO insertions located in the protease III gene ( Fig. 2; 5) . In Fig. 2 , lane 8, a truncated polypeptide of 62,000 Mr is seen as well as the 50,000Mr polypeptide. The size of this polypeptide is in agreement with the physical location of the TnJO00-71 insertion in Fig. 1 . Lane 9 shows a truncated polypeptide of 74,000 and the 50,000Mr polypeptide, since the Tnl000-73 insertion is located at the carboxyl end of the protease III gene. The third TnJOOO insertion (Tnl000-24) causes the production of a truncated polypeptide of 32,000 Mr which is masked by the thyA gene product of 33,000 Mr in whole-cell extracts (Fig. 2, lane 5) , but is easily seen in the 1 2 3 4 5 6 7 8 9 10 'a .. To see whether the p50 polypeptide is encoded in the same reading frame as the protease III gene product, the S. aureus V-8 protease (7) digests of each protein were compared by polyacrylamide gel electrophoresis (4) . Almost all of the bands of the digested p5O protein had a corresponding band in the pllO digest (data not shown).
Periplasmic extracts were incubated at 37°C in protease III assay buffer for various time periods, and the relative amounts of p50 versus pllO were measured electrophoretically. No change was seen in the amounts of either protein, indicating the p5O did not arise from the autolysis of pllO in vitro (data not shown). Subsequent results suggested either autolysis or processing of pllO to yield p5O in vivo.
To determine whether the p5O product resulted from either an early transcriptional or translational termination or was processed from the completed p110, a pulse-chase experi- bOne unit equals the degradation of 1 pLg of 0-insulin in 1 h at 37°C. Enzyme activity was assayed as described in the text. ment was performed. At the first time point of 10 min, pllO labeled well but no p5O was evident (Fig. 3) . The chase period began after 20 min of labeling with the addition of unlabeled methionine as well as spectinomycin to inhibit further protein synthesis. As the chase continued for 90 min, p50 accumulated while the amount of pllO in the periplasm did not increase, as determined by densitometric tracings of the autoradiogram.
Enzyme activity. Since protease III is the only periplasmic enzyme in E. coli known to degrade insulin, the amount of activity encoded by the various plasmids was tested. Periplasmic extracts from strains containing either pCDK35 or pCDK3 had an approximately 7-to 13-fold increase in insulin-degrading activity as compared with strains with only pBR325 (Table 2 ). In contrast, strains carrying TnlOOOinsertions in the ptr gene did not overproduce insulindegrading activity ( Hydroxyapatite chromatography. Fraction III was applied to a hydroxyapatite column (2.0-cm diameter, 10-ml bed volume) equilibrated with buffer B. The column was washed with 100 ml of buffer B. A gradient of 0.02 to 0.2 M potassium phosphate (pH 7.0) was applied to the column. Protease III eluted midway through the gradient. The appropriate fractions were collected and dialyzed into buffer A (fraction IV).
DEAE-Sephadex chromatography. Fraction IV was applied to a DEAE-Sephadex column (2.0-cm diameter, 20-ml bed volume) that had been equilibrated with buffer A. The column was washed with 100 ml of buffer A. The absorbed proteins were eluted with 150 ml of 0 to 0.25 M NaCl in buffer A. Protease III eluted at approximately 0.15 M NaCl (see Fig. 4 ). The active fractions were pooled and dialyzed against buffer A that was 50% in glycerol, and these fractions were kept at -20°C (fraction V). A profile of this column is shown in Fig. 4 . The procedure resulted in a 7.1% recovery (Table 3 ) of enzyme greater than 95% pure (Fig. 5) (Fig. 2) . The p50 product is found in the periplasm, as is protease III, and surprisingly, the truncated polypeptides produced as a result of various TnJOOO insertions are also periplasmically located. This result suggests that secretion requires only the aminoterminal portion of the protein, in contrast to the requirement of a central region for P-lactamase (9). Limited Table 2) . The pulse-chase maxicell experiment demonstrated that although protease III is made and transported to the periplasm quite rapidly, the p5O product appears in the periplasm at a slower rate. Even after 90 min of labeling, there was 50% less of the p5O product than of the protease III product, as determined by densitometric analysis of the autoradiographs. Since new protein synthesis was inhibited after 20 min of labeling with [35S]methionine, it was expected that the amount of protease III observed would decrease as the amount of p5O increased. Surprisingly, only the level of p5O increased with time. Since little p5O was seen from wholecell extracts that had been osmotically shocked (Fig. 2, lanes  1 through 5) , we believe that p5O is predominantly produced in the periplasm. However, the poor response of UVirradiated CRS603 cells to osmotic shock precludes any definite conclusion at this time. The role of this protein has not been identified. It is possible that p50 is merely a stable specific breakdown product of protease III. This would explain its increase with time except for the fact that the amount of protease III does not appear to decrease coordinately. It is possible that there is only room in the periplasmic space for a certain amount of protease III, and after that point, p5O begins to accumulate. Degradation of periplasmically located protease III would permit the export of additional pllO protein from the cytoplasm, resulting in the apparent constant levels seen in Fig. 3 .
The protease III purification procedure presented here is much simpler than any other previously described method. The methods presented by Goldberg et al. (6) and Cheng and Zipser (2) both require additional chromatography steps with considerably lower yields. In addition, the use of an osmotic shock retains most of the cytoplasmic proteins in the first step.
Since the protease III structural gene can be deleted from E. coli chromosome without any apparent detrimental effects, its activity cannot be essential for normal metabolism in the cell. Conversely, overexpression of protease III upon cloning the gene on a multicopy plasmid also does not appear to have any effects on cell viability. This raises several questions on the regulation of expression of protease III in the cell. Assuming that protease III is involved in the degradation of unwanted proteins, it would need to be available at only certain times and places. It is possible that protease III is functionally compartmentalized in some fashion. The presence of an inhibitor of the enzyme could also be a factor in its regulation.
